Cellectar Biosciences, Inc. Unrecognized Tax Benefits, Period Increase (Decrease)
Cellectar Biosciences, Inc. (CLRB) reported Unrecognized Tax Benefits, Period Increase (Decrease) of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Income Taxes
us-gaap:UnrecognizedTaxBenefitsPeriodIncreaseDecrease · last filed 2026-08-13
- Cellectar Biosciences, Inc. unrecognized tax benefits, period increase (decrease) for the quarter ending 2026-06-30 was $0.00.
- Cellectar Biosciences, Inc. unrecognized tax benefits, period increase (decrease) for the quarter ending 2026-03-31 was $0.00.
- Cellectar Biosciences, Inc. unrecognized tax benefits, period increase (decrease) for the quarter ending 2025-12-31 was $0.00.
- Cellectar Biosciences, Inc. unrecognized tax benefits, period increase (decrease) for the quarter ending 2025-09-30 was $0.00.
| Period end | Unrecognized Tax Benefits, Period Increase (Decrease) 3 month | Unrecognized Tax Benefits, Period Increase (Decrease) 6 month | Unrecognized Tax Benefits, Period Increase (Decrease) 9 month | Unrecognized Tax Benefits, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | |
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | $0.00 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |